Astellas Pharma
Xiaozhu Duan has extensive experience in the pharmaceutical and biotechnology sectors, specializing in analytical development and assay methodologies. Currently serving as the Head of Analytical Development at Astellas Gene Therapies from January 2021 to April 2024, previously held the position of Associate Director in the same department. Prior roles include Senior Manager of CMC Analytical Development at Audentes Therapeutics and Manager/Scientist of Potency and Bio-analytical Assays at both Pfizer and Medivation. Xiaozhu began a career in assay development with a long tenure as Sr. Scientist at Diadexus and as Sr. Associate at Avigen. Academic qualifications include a Master’s degree in Molecular Genetics from Iowa State University and a Bachelor’s degree in Biochemistry from Sichuan University.
This person is not in any teams
This person is not in any offices